← Evidence map

ArticlemAbs2015

A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.

Uwe Reusch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

80 papers cite itlatest 60 shown

2015
…
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25875246